Therapeutic Hypothermia After Cardiac Arrest Clinical Application and Management /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Lundbye, Justin B. (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: London : Springer London : Imprint: Springer, 2012.
• Θέματα: Medicine.; Emergency medicine.; Critical care medicine.; Cardiology.; Cardiac surgery.; Medicine & Public Health.; Emergency Medicine.; Intensive / Critical Care Medicine.; Cardiac Surgery.

 Therapeutic hypothermia (TH) has emerged as an important treatment option for patients resuscitated from cardiac arrest as it provides significant protection from developing neurologic injury.  Although hospitals and medical centres have become familiar with this intervention, it still remains greatly under-utilized due to a lack of experience and resources to deploy such a program safely and effectively. Therapeutic Hypothermia After Cardiac Arrest provides an evidence-based approach to identifying and managing cardiac arrest patients who are appropriate for TH.  The Editor has assembled a team of prominent experts in the field to provide a practical “how-to” book that presents the reader with the necessary tools to design, apply and successfully manage a TH program at their institution. As such, this book will address the needs of emergency medicine physicians and staff, intensivists, internists, cardiologists, cardiac surgeons, interventionalists and nursing staff. 

 1. Introduction -- 2. Pre-hospital therapeutic hypothermia.-3. Molecular Mechanism of Reperfusion Injury -- 4. Cardiac Arrest: Who Should Be Cooled? -- 5. Hypothermia: How to Cool -- 6. How to Implement Therapeutic Hypothermia in the Hospital -- 7. Post-Cardiac Arrest: How to Develop and Implement a Standard Therapeutic Hypothermia Protocol? -- 8. Complications of Therapeutic Hypothermia Following Cardiac Arrest -- 9. Pharmacology & Therapeutic Hypothermia -- 10. Determination of Neurological Prognosis -- 11. Therapeutic hypothermia as a treatment of myocardial infarction and cardiogenic shock.